Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Cryoelectron Microscopy | 13 | 2021 | 2372 | 1.33 | Why? |
| Spike Glycoprotein, Coronavirus | 24 | 2021 | 37182 | 0.98 | Why? |
| Membrane Fusion | 4 | 2021 | 713 | 0.72 | Why? |
| Protein Multimerization | 5 | 2020 | 1336 | 0.69 | Why? |
| Models, Molecular | 14 | 2021 | 7616 | 0.62 | Why? |
| Antibodies, Neutralizing | 18 | 2021 | 25288 | 0.54 | Why? |
| Protein Domains | 7 | 2021 | 6563 | 0.53 | Why? |
| Polysaccharides | 2 | 2018 | 854 | 0.47 | Why? |
| Coronavirus NL63, Human | 2 | 2018 | 669 | 0.45 | Why? |
| Nanoparticles | 3 | 2021 | 2040 | 0.41 | Why? |
| Epitopes | 4 | 2021 | 4113 | 0.40 | Why? |
| Antibodies, Monoclonal | 12 | 2021 | 8041 | 0.37 | Why? |
| Drosophila | 2 | 2017 | 55 | 0.34 | Why? |
| HEK293 Cells | 9 | 2021 | 8394 | 0.34 | Why? |
| Murine hepatitis virus | 1 | 2016 | 1720 | 0.32 | Why? |
| Immune Evasion | 5 | 2021 | 2081 | 0.29 | Why? |
| Cross Reactions | 5 | 2021 | 4374 | 0.26 | Why? |
| Protein Conformation | 6 | 2021 | 4386 | 0.25 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 3 | 2019 | 8843 | 0.22 | Why? |
| Macaca nemestrina | 1 | 2020 | 71 | 0.22 | Why? |
| Virus Internalization | 5 | 2021 | 7921 | 0.22 | Why? |
| Protein Engineering | 2 | 2021 | 536 | 0.21 | Why? |
| Antibodies, Viral | 12 | 2021 | 51949 | 0.21 | Why? |
| Mutation | 8 | 2021 | 12376 | 0.21 | Why? |
| Cell Line | 5 | 2021 | 12040 | 0.21 | Why? |
| Alphavirus | 1 | 2020 | 90 | 0.20 | Why? |
| Animals | 17 | 2021 | 78931 | 0.19 | Why? |
| Drosophila melanogaster | 2 | 2018 | 85 | 0.19 | Why? |
| Protein Structure, Quaternary | 2 | 2020 | 455 | 0.19 | Why? |
| Epitope Mapping | 2 | 2021 | 1240 | 0.19 | Why? |
| Replicon | 1 | 2020 | 232 | 0.18 | Why? |
| Receptors, Cell Surface | 2 | 2021 | 586 | 0.18 | Why? |
| Lectins | 1 | 2021 | 311 | 0.18 | Why? |
| Amino Acid Sequence | 3 | 2020 | 6049 | 0.18 | Why? |
| Sialic Acids | 1 | 2019 | 218 | 0.18 | Why? |
| Aptamers, Nucleotide | 1 | 2021 | 265 | 0.18 | Why? |
| Vitrification | 1 | 2017 | 22 | 0.17 | Why? |
| Vero Cells | 5 | 2021 | 14117 | 0.17 | Why? |
| N-Acetylneuraminic Acid | 1 | 2019 | 198 | 0.17 | Why? |
| Molecular Mimicry | 1 | 2019 | 190 | 0.17 | Why? |
| Peptidyl-Dipeptidase A | 5 | 2020 | 9659 | 0.16 | Why? |
| Protein Binding | 7 | 2021 | 11430 | 0.16 | Why? |
| Mice, Inbred BALB C | 3 | 2021 | 5814 | 0.15 | Why? |
| Antigens, Viral | 3 | 2021 | 6298 | 0.14 | Why? |
| Vaccination | 1 | 2020 | 19050 | 0.14 | Why? |
| Vaccines, Subunit | 1 | 2021 | 1088 | 0.14 | Why? |
| Antibodies | 1 | 2021 | 846 | 0.14 | Why? |
| Immunization Schedule | 1 | 2021 | 1305 | 0.13 | Why? |
| Viral Vaccines | 3 | 2021 | 7560 | 0.13 | Why? |
| Coronaviridae Infections | 1 | 2018 | 442 | 0.13 | Why? |
| Glycoproteins | 1 | 2018 | 615 | 0.13 | Why? |
| Nanostructures | 1 | 2021 | 700 | 0.13 | Why? |
| Cricetinae | 4 | 2021 | 3344 | 0.13 | Why? |
| Visitors to Patients | 1 | 2020 | 671 | 0.13 | Why? |
| Neutralization Tests | 6 | 2021 | 6698 | 0.13 | Why? |
| Receptors, Virus | 2 | 2020 | 5659 | 0.12 | Why? |
| SARS Virus | 3 | 2020 | 13021 | 0.11 | Why? |
| Mass Spectrometry | 1 | 2017 | 1165 | 0.11 | Why? |
| Coronaviridae | 1 | 2018 | 923 | 0.11 | Why? |
| Adjuvants, Immunologic | 1 | 2021 | 1709 | 0.11 | Why? |
| Protein Structure, Tertiary | 1 | 2016 | 1565 | 0.11 | Why? |
| Coronavirus OC43, Human | 1 | 2019 | 1157 | 0.11 | Why? |
| Betacoronavirus | 9 | 2021 | 204454 | 0.11 | Why? |
| Virus Attachment | 1 | 2018 | 1259 | 0.10 | Why? |
| Molecular Sequence Data | 1 | 2016 | 3198 | 0.10 | Why? |
| Coronavirus | 1 | 2019 | 18339 | 0.10 | Why? |
| Molecular Dynamics Simulation | 2 | 2020 | 4155 | 0.09 | Why? |
| Seasons | 1 | 2021 | 4071 | 0.09 | Why? |
| Drug Design | 1 | 2020 | 2627 | 0.09 | Why? |
| Vaccines, Synthetic | 1 | 2021 | 3231 | 0.09 | Why? |
| Molecular Docking Simulation | 2 | 2020 | 6902 | 0.09 | Why? |
| Immunity, Humoral | 2 | 2021 | 4849 | 0.09 | Why? |
| Immunoglobulin Fab Fragments | 2 | 2021 | 556 | 0.09 | Why? |
| Binding Sites | 4 | 2020 | 6201 | 0.08 | Why? |
| Immunoglobulin Fc Fragments | 2 | 2021 | 691 | 0.08 | Why? |
| Mice | 4 | 2021 | 21357 | 0.08 | Why? |
| T-Lymphocytes | 2 | 2021 | 6670 | 0.08 | Why? |
| Mesocricetus | 2 | 2021 | 1847 | 0.08 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.07 | Why? |
| Humans | 24 | 2021 | 930598 | 0.07 | Why? |
| Signal Transduction | 1 | 2021 | 7207 | 0.07 | Why? |
| Coronavirus Infections | 10 | 2021 | 253789 | 0.07 | Why? |
| Epitopes, B-Lymphocyte | 2 | 2021 | 1267 | 0.06 | Why? |
| Linoleic Acids | 1 | 2021 | 51 | 0.06 | Why? |
| Genes, Synthetic | 1 | 2021 | 39 | 0.06 | Why? |
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2021 | 40 | 0.06 | Why? |
| Receptor, TIE-2 | 1 | 2021 | 42 | 0.06 | Why? |
| Angiopoietins | 1 | 2021 | 45 | 0.06 | Why? |
| Peptide Mapping | 1 | 2021 | 112 | 0.06 | Why? |
| Inorganic Chemicals | 1 | 2020 | 23 | 0.06 | Why? |
| Jurkat Cells | 1 | 2021 | 273 | 0.05 | Why? |
| CD40 Antigens | 1 | 2021 | 118 | 0.05 | Why? |
| Hemagglutination, Viral | 1 | 2019 | 31 | 0.05 | Why? |
| Carbohydrate Conformation | 1 | 2019 | 46 | 0.05 | Why? |
| Oligodeoxyribonucleotides | 1 | 2021 | 206 | 0.05 | Why? |
| Sialic Acid Binding Ig-like Lectin 1 | 1 | 2021 | 156 | 0.05 | Why? |
| Electrophoresis, Polyacrylamide Gel | 1 | 2020 | 238 | 0.05 | Why? |
| Squalene | 1 | 2021 | 196 | 0.05 | Why? |
| Alum Compounds | 1 | 2021 | 210 | 0.05 | Why? |
| Cell Fusion | 1 | 2021 | 400 | 0.05 | Why? |
| Viral Proteins | 1 | 2018 | 7370 | 0.05 | Why? |
| Disulfides | 1 | 2020 | 161 | 0.05 | Why? |
| Protein Conformation, alpha-Helical | 1 | 2021 | 530 | 0.05 | Why? |
| Clinical Trials, Phase I as Topic | 1 | 2021 | 242 | 0.05 | Why? |
| Protein Folding | 1 | 2020 | 270 | 0.05 | Why? |
| Antigen-Antibody Reactions | 1 | 2020 | 616 | 0.05 | Why? |
| Saccharomyces cerevisiae | 1 | 2020 | 339 | 0.05 | Why? |
| Lectins, C-Type | 1 | 2021 | 405 | 0.05 | Why? |
| Protein Subunits | 1 | 2021 | 755 | 0.04 | Why? |
| Cell Adhesion Molecules | 1 | 2021 | 472 | 0.04 | Why? |
| Antibody-Dependent Cell Cytotoxicity | 1 | 2020 | 349 | 0.04 | Why? |
| Methods | 1 | 2017 | 19 | 0.04 | Why? |
| Clinical Trials, Phase II as Topic | 1 | 2021 | 801 | 0.04 | Why? |
| Protein Stability | 1 | 2020 | 756 | 0.04 | Why? |
| Protein Interaction Mapping | 1 | 2019 | 487 | 0.04 | Why? |
| Primates | 1 | 2020 | 584 | 0.04 | Why? |
| Freezing | 1 | 2017 | 106 | 0.04 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.04 | Why? |
| Macromolecular Substances | 1 | 2017 | 103 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Antibody Affinity | 1 | 2021 | 1078 | 0.04 | Why? |
| RNA, Viral | 2 | 2021 | 32276 | 0.04 | Why? |
| B-Lymphocytes | 2 | 2021 | 4418 | 0.04 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 7868 | 0.04 | Why? |
| Female | 8 | 2021 | 380317 | 0.03 | Why? |
| Amino Acid Substitution | 1 | 2021 | 1706 | 0.03 | Why? |
| Protein Interaction Domains and Motifs | 1 | 2021 | 2134 | 0.03 | Why? |
| Cell Proliferation | 1 | 2021 | 1973 | 0.03 | Why? |
| Lipids | 1 | 2020 | 1079 | 0.03 | Why? |
| Adolescent | 2 | 2020 | 86841 | 0.03 | Why? |
| Structure-Activity Relationship | 1 | 2019 | 2219 | 0.03 | Why? |
| Disease Models, Animal | 2 | 2021 | 10998 | 0.03 | Why? |
| Dipeptidyl Peptidase 4 | 1 | 2019 | 1061 | 0.03 | Why? |
| Cell Line, Tumor | 1 | 2021 | 3608 | 0.03 | Why? |
| Kinetics | 1 | 2020 | 3238 | 0.03 | Why? |
| HIV | 1 | 2018 | 1116 | 0.03 | Why? |
| Lymphocyte Activation | 1 | 2021 | 2742 | 0.03 | Why? |
| Crystallography, X-Ray | 1 | 2018 | 2689 | 0.03 | Why? |
| Macaca mulatta | 1 | 2021 | 3716 | 0.03 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.03 | Why? |
| Killer Cells, Natural | 1 | 2020 | 2093 | 0.03 | Why? |
| Male | 5 | 2021 | 367725 | 0.02 | Why? |
| Aged | 3 | 2021 | 215776 | 0.02 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2020 | 5542 | 0.02 | Why? |
| Phenotype | 1 | 2020 | 4037 | 0.02 | Why? |
| Genotype | 1 | 2021 | 4697 | 0.02 | Why? |
| Swine | 1 | 2018 | 3352 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.02 | Why? |
| Middle Aged | 3 | 2021 | 270681 | 0.02 | Why? |
| Swine Diseases | 1 | 2018 | 1219 | 0.02 | Why? |
| Immunologic Memory | 1 | 2020 | 3362 | 0.02 | Why? |
| Immunity, Cellular | 1 | 2021 | 3614 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Genetic Variation | 1 | 2021 | 3919 | 0.02 | Why? |
| Software | 1 | 2018 | 2501 | 0.02 | Why? |
| Antibody Formation | 1 | 2020 | 4038 | 0.02 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.02 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.02 | Why? |
| Adult | 2 | 2021 | 244371 | 0.02 | Why? |
| Computer Simulation | 1 | 2021 | 4982 | 0.02 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4545 | 0.02 | Why? |
| Immunization, Passive | 1 | 2021 | 10067 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.02 | Why? |
| Europe | 1 | 2021 | 12702 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.02 | Why? |
| Travel | 1 | 2021 | 7220 | 0.01 | Why? |
| Phylogeny | 1 | 2021 | 13341 | 0.01 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Specimen Handling | 1 | 2017 | 6190 | 0.01 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Infant | 1 | 2020 | 30274 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.01 | Why? |
| Child, Preschool | 1 | 2020 | 36283 | 0.01 | Why? |
| Pandemics | 5 | 2020 | 389249 | 0.01 | Why? |
| Prospective Studies | 1 | 2020 | 43301 | 0.01 | Why? |
| Treatment Outcome | 1 | 2021 | 51732 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| United States | 1 | 2020 | 46150 | 0.01 | Why? |
| Lung | 1 | 2021 | 31049 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2021 | 88759 | 0.01 | Why? |
Walls's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(184)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(342)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_